Free Trial
NASDAQ:RDHL

Redhill Biopharma (RDHL) Stock Price, News & Analysis

Redhill Biopharma logo
$2.06 +0.03 (+1.48%)
Closing price 03:59 PM Eastern
Extended Trading
$2.04 -0.02 (-0.97%)
As of 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Redhill Biopharma Stock (NASDAQ:RDHL)

Key Stats

Today's Range
$2.01
$2.06
50-Day Range
$1.75
$2.23
52-Week Range
$1.71
$20.28
Volume
12,504 shs
Average Volume
164,085 shs
Market Capitalization
$4.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RDHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Redhill Biopharma and its competitors with MarketBeat's FREE daily newsletter.

RDHL Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
RedHill Biopharma Ltd. (RDHL) - Yahoo Finance
See More Headlines

RDHL Stock Analysis - Frequently Asked Questions

Redhill Biopharma's stock was trading at $6.21 at the start of the year. Since then, RDHL stock has decreased by 66.8% and is now trading at $2.06.

Redhill Biopharma Ltd. (NASDAQ:RDHL) released its quarterly earnings data on Tuesday, November, 30th. The biotechnology company reported ($500.00) EPS for the quarter, missing the consensus estimate of ($480.00) by $20.00. The biotechnology company earned $21.61 million during the quarter, compared to analysts' expectations of $23.41 million.

Redhill Biopharma's stock reverse split before market open on Tuesday, August 20th 2024.The 1-25 reverse split was announced on Friday, August 16th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 19th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of RDHL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Redhill Biopharma investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Adobe (ADBE), Broadcom (AVGO), CymaBay Therapeutics (CBAY) and AbbVie (ABBV).

Company Calendar

Last Earnings
11/30/2021
Today
7/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RDHL
Previous Symbol
ASX:RDH
Employees
210
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.04 million
Price / Cash Flow
N/A
Book Value
($3.66) per share
Price / Book
-0.56

Miscellaneous

Free Float
2,136,000
Market Cap
$4.66 million
Optionable
No Data
Beta
4.22

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:RDHL) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners